ZIF-8 as a pH-Responsive Nanoplatform for 5-Fluorouracil Delivery in the Chemotherapy of Oral Squamous Cell Carcinoma
International Journal of Molecular Sciences · 27.08.2024 · 25 (17) · 9292
DOI: 10.3390/ijms25179292 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.08.2024. Verfasst von Jessica Hao und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19019, USA. Hauptthemen laut MEDLINE: Fluorouracil, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIH.
Themen: Onkologische Pflege
Abstract (Originalsprache)
5-fluorouracil (5-FU), a chemotherapeutic agent against oral squamous cell carcinoma (OSCC), is limited by poor pharmacokinetics and toxicity. The pH-sensitive zeolite imidazolate framework-8 (ZIF-8) may increase the selectivity and length of 5-FU released into the acidic tumor microenvironment. This study examined the in vitro 5-FU absorption and release profiles of ZIF-8, and then progressed to cytotoxicity assays using the OSCC primary cell line SCC7. The 5-FU loading capacity of ZIF-8 was calculated with UV-vis spectroscopy (λ = 260 nm). 5-FU release was quantified by submerging 5-FU@ZIF-8 in pH 7.4 and 5.5 acetate buffer over 48 h. For the cytotoxicity assays, 5-FU, ZIF-8, and 5-FU@ZIF-8 were added to SCC7 cultures at 25, 50, and 100 μg/mL. Cell viability was assessed through toluidine blue staining and further quantified through transcriptomic RNA sequencing. ZIF-8 stabilized at a maximum absorption of 2.71 ± 0.22 mg 5-FU, and released 0.66 mg more 5-FU at pH 5.5 than 7.4 for at least 72 h. The cytotoxicity assays showed that 5-FU@ZIF-8 had a synergistic inhibitory effect at 50 μg/mL. The RNA sequencing analysis further revealed the molecular targets of 5-FU@ZIF-8 in SCC7. 5-FU@ZIF-8 may release 5-FU based on the pH of the surrounding microenvironments and synergistically inhibit OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19019, USA.
- Oral and Maxillofacial Surgery, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Faculty of Medicine, Juraj Dobrila University of Pula, 52100 Pula, Croatia.
- Preventative and Restorative Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
ORCID-Profile: Jessica Hao, Chider Chen, Kresimir Pavelic
Förderung
- NIH HHS
- NIH
Zitieren
APA
Hao, J., Chen, C., Pavelic, K., & Ozer, F. (2024). ZIF-8 as a pH-Responsive Nanoplatform for 5-Fluorouracil Delivery in the Chemotherapy of Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences, 25(17), 9292. https://doi.org/10.3390/ijms25179292
Vancouver
Hao J, Chen C, Pavelic K, Ozer F. ZIF-8 as a pH-Responsive Nanoplatform for 5-Fluorouracil Delivery in the Chemotherapy of Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2024;25(17):9292. doi:10.3390/ijms25179292
BibTeX
@article{Hao2024,
author = {Hao, Jessica and Chen, Chider and Pavelic, Kresimir and Ozer, Fusun},
title = {ZIF-8 as a pH-Responsive Nanoplatform for 5-Fluorouracil Delivery in the Chemotherapy of Oral Squamous Cell Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {17},
pages = {9292},
doi = {10.3390/ijms25179292}
}
EUVIMED